PCA
BTX.WS

Providence Capital Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Providence Capital Advisors’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-19
Closed – – 271
2018
Q2 		$0 Hold
19
– – ﹤0.01% 264
2018
Q1 		$0 Buy
+19
New +$3 ﹤0.01% 318

Providence Capital Advisors's BTX.WS Position: Q3 2018 in Review

Providence Capital Advisors sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 19 shares.

Providence Capital Advisors first reported a position in BTX.WS in Q1 2018 and held it in 2 quarters. The position peaked at $0 in Q2 2018. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • Providence Capital Advisors reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • Providence Capital Advisors sold 19 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • Providence Capital Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q1 2018 and held it in 2 quarters.
  • Providence Capital Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q2 2018.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on Providence Capital Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.